🎄📦 Due to Xmas & New Year, the next dispatch dates are: 23rd Dec, 27th Dec, 30th Dec, and 2nd Jan.
🎄📦 Due to Xmas & New Year, the next dispatch dates are: 23rd Dec, 27th Dec, 30th Dec, and 2nd Jan.
£9.99
Variety of delivery options including next day & free delivery.
Pharmacy, clinic and prescribers based in Greater Manchester.
Start your treatment with a quick and free online consultation.
Variety of delivery options including next day & free delivery.
Pharmacy, clinic and prescribers based in Greater Manchester.
Start your treatment with a quick and free online consultation.
Fill in a quick online consultation for our licensed pharmacists to review.
Our pharmacists will review your treatment to ensure it’s suitable.
Your treatment will be delivered to your door quickly & discretely.
Migraleve complete is a medication that contains two active ingredients: paracetamol and codeine phosphate. It is used to treat moderate to severe migraine headaches. Migraleve complete comes in the form of pink and yellow tablets, with the pink tablets containing paracetamol and codeine phosphate, and the yellow tablets containing buclizine.
Migraleve complete is primarily used for the treatment of migraines and severe headaches. The combination of paracetamol and codeine phosphate provides effective relief from the pain and discomfort associated with migraines. In addition to migraines, Migraleve complete can also be used to alleviate symptoms of tension headaches and other types of severe headaches.
Paracetamol works by blocking the production of prostaglandins in the brain, which are chemicals that cause pain and inflammation. Codeine phosphate is an opioid analgesic that works by binding to opioid receptors in the brain and spinal cord, reducing the perception of pain. Buclizine, found in the yellow tablets, is an antihistamine that helps to reduce nausea and vomiting associated with migraines.
Migraleve complete is suitable for adults and children over the age of 12 who are experiencing moderate to severe migraines or headaches. It is important to follow the recommended dosage and usage instructions provided with the medication. Migraleve complete is not suitable for individuals who are allergic to any of the active or inactive ingredients, or for those with certain medical conditions such as respiratory depression, acute asthma, or liver disease.
To take Migraleve complete, follow these steps:
1. Take two pink tablets at the first sign of a migraine attack.
2. If necessary, take two yellow tablets after 4 hours.
3. Do not take more than 8 tablets in a 24-hour period.
4. Do not take Migraleve complete for more than 3 days in a row.
It is important to carefully read and follow the dosage instructions provided in the patient information leaflet before taking Migraleve complete. If you are unsure about how to take this medication, consult your doctor or pharmacist for guidance.
Active Ingredients: Each pink tablet contains 500mg of paracetamol and 8mg of codeine phosphate. Each yellow tablet contains 50mg of buclizine.
Other ingredients: The other ingredients in Migraleve complete include maize starch, colloidal anhydrous silica, magnesium stearate, and talc.
When taking Migraleve complete, it is important to be aware of the following warnings and precautions:
– Do not exceed the recommended dosage or take the medication for longer than advised.
– Migraleve complete may cause drowsiness, so avoid driving or operating heavy machinery while taking this medication.
– Avoid consuming alcohol while taking Migraleve complete, as it can increase the risk of side effects.
– If you are pregnant, breastfeeding, or have any underlying medical conditions, consult your doctor or pharmacist before taking Migraleve complete.
It is important to carefully read the patient information leaflet provided with Migraleve complete before use. If you have any questions or concerns about this medication, speak to your doctor or pharmacist for further advice.
For more detailed information, please refer to the patient information leaflet for Migraleve complete:
– Pink tablets: [Link to patient information leaflet for pink tablets]
– Yellow tablets: [Link to patient information leaflet for yellow tablets]
